{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["10(1)"],"submitter":["Zhuang Y"],"funding":["Fujian Clinical Medical Research Center for Immune Kidney Disease","This study was supported by grants from the Key Clinical Specialty Discipline Construction Program of Fujian"],"journal":["Chronic diseases and translational medicine"],"pagination":["1-11"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10914012"],"repository":["biostudies-literature"],"pubmed_title":["Advances in the treatment of IgA nephropathy with biological agents"],"pmcid":["PMC10914012"],"funding_grant_id":["2017ZDZKSB","2021Y2016"],"pubmed_authors":["Li J","Lu H","Zhuang Y"],"additional_accession":[]},"is_claimable":false,"name":"Advances in the treatment of IgA nephropathy with biological agents","description":null,"dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Dec","modification":"2024-11-14T22:19:46.733Z","creation":"2024-11-14T22:19:46.733Z"},"accession":"S-EPMC10914012","cross_references":{}}